• Center for Innovation in Brain Science

Home Page

Innovative Brain Science of the Future for Those Who Need a Cure Today


Our Strategy

In the 21st century, there is not a single therapeutic that cures a single neurological disease. 

Our Functions

Our Functions

Seven operating functions enable development of therapeutics for the Center for Innovation Brain Science.

Our Partners

Our Partners

Public / private partnerships between academia and industry are key elements to advancing therapeutic development and innovation.



News & Announcements

Department of Pharmacology receives funds from the NIA/NIH to study Aging and Estrogenic Control of the Bioenergetic System in Brain
March 16, 2017

For estrogen to function as master regulator of the bioenergetic system in the female brain, estrogen must be integrating nuclear and mitochondrial genomic responses. Further, from a systems level perspective, it would be necessary for estrogen to also regulate cytoplasmic signaling mechanisms for real time feedback on the functional outcomes of nuclear and mitochondrial gene transcription. The fundamental issues to be investigated are the mechanisms whereby estrogen integrates bioenergetic responses across two genomic compartments while simultaneously monitoring energetic demand and performance in real time. Estrogenic control of the bioenergetic system of the brain and the dismantling thereof has basic, translational and clinical significance.

Alzheimer’s Researcher and CIBS Director, Dr. Roberta Diaz Brinton, named one of 17 Disruptive Women to Watch in 2017
January 30, 2017

Disruptive Women seeks to highlight women from a broad cross-section of disciplines, all of whom profoundly impact health and health care. This year we are doing something different. Given the enormity of the issues we are facing globally, when it comes to Alzheimer’s Disease and related dementias, we are focusing this year’s class of extraordinary women on those who are committed to ridding the world of this scourge.

Here’s Maria Shriver’s Challenge to Corporate America on Alzheimer’s
November 2, 2016

She says companies don’t find Alzheimer’s, which disproportionately affects women, “sexy”. Each October, a parade of major American companies across the business spectrum unite to promote women’s health for Breast Cancer Awareness Month. But there’s not nearly as much corporate activism when it comes to another disease with a massive gender gap: Alzheimer’s. And that needs to change if there’s any hope for finding a cure, argues journalist and activist Maria Shriver.